Global Albumin

Albumin Comprehensive Study by Type (Human Serum Albumin, Recombinant Albumin), Application (Drug Formulation, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics, In Vitro Fertilization), End Use Sectors (Pharmaceutical & Biotechnology Industry, Research Institutes) Players and Region - Global Market Outlook to 2030

Albumin Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Albumin is a water soluble globular protein produced in the liver which accounts for 50% of blood plasma proteins that plays a vital role in regulating blood volume & act as transporters for molecules such as few hormones, bile salts, & ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, & other blood loss trauma & surgeries. However, usage of albumin as multi-functional excipient is increasing due to rise in consumption for applications such as drug formulation, vaccines, drug discovery, culture medium, stabilizing agent, & diagnostics.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAlbumedix (Denmark), Albumin Therapeutics, LLC (United States), Biotest AG (Germany), Octapharma AG (Switzerland), CSL Behring LLC (United States), Baxter International, Inc. (United States), HiMedia Laboratories (India), MedxBio Pte. Ltd. (Singapore), Novozymes A/S. (Denmark) and Mitsubishi Tanabe Pharma (Japan)


This growth is primarily driven by High Demand for Albumin in R&D Activities, Rise in Non-Therapeutic Application of Albumin and Rising Plasma Collection.

Globally, a noticeable market trend is evident Technological Development Major Players, such as Albumedix (Denmark), Albumin Therapeutics, LLC (United States), Biotest AG (Germany), Octapharma AG (Switzerland), CSL Behring LLC (United States), Baxter International, Inc. (United States), HiMedia Laboratories (India), MedxBio Pte. Ltd. (Singapore), Novozymes A/S. (Denmark) and Mitsubishi Tanabe Pharma (Japan), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The companies are focusing on partnering with leading pharmaceutical companies to boost the research & development activities in order to develop technologically advanced albumin products.

Influencing Trend:
Technological Development and Rising Production of Immunoglobulins that uses albumin

Market Growth Drivers:
High Demand for Albumin in R&D Activities, Rise in Non-Therapeutic Application of Albumin and Rising Plasma Collection

Challenges:
Pricing Pressure Faced By Prominent Player in the Market and High Competition From Substitute Products

Restraints:
Adverse Reactions Associated With Albumin, Limited Reimbursement and Stringent Regulations

Opportunities:
Expanding Applications of Albumin and Focus on Emerging Regions to Provide Immense Potential

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Albumin Market
- Analysis about New Entrants in Albumin Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Albumin Study Sheds Light on
— The Albumin Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Albumin industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Albumin industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Human Serum Albumin
  • Recombinant Albumin
By Application
  • Drug Formulation
  • Vaccines
  • Medical Device Coating
  • Culture Medium & Stabilizer
  • Diagnostics
  • In Vitro Fertilization
By End Use Sectors
  • Pharmaceutical & Biotechnology Industry
  • Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand for Albumin in R&D Activities
      • 3.2.2. Rise in Non-Therapeutic Application of Albumin
      • 3.2.3. Rising Plasma Collection
    • 3.3. Market Challenges
      • 3.3.1. Pricing Pressure Faced By Prominent Player in the Market
      • 3.3.2. High Competition From Substitute Products
    • 3.4. Market Trends
      • 3.4.1. Technological Development
      • 3.4.2. Rising Production of Immunoglobulins that uses albumin
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Albumin, by Type, Application, End Use Sectors and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Albumin (Price)
      • 5.2.1. Global Albumin by: Type (Price)
  • 6. Albumin: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Albumedix (Denmark)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Albumin Therapeutics, LLC (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Biotest AG (Germany)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Octapharma AG (Switzerland)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. CSL Behring LLC (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Baxter International, Inc. (United States)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. HiMedia Laboratories (India)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. MedxBio Pte. Ltd. (Singapore)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Novozymes A/S. (Denmark)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Mitsubishi Tanabe Pharma (Japan)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Albumin Sale, by Type, Application, End Use Sectors and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Albumin (Price)
      • 7.2.1. Global Albumin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Albumin: by Type(USD/Units)
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Company Basic Information, Sales Area and Its Competitors
  • Table 11. Company Basic Information, Sales Area and Its Competitors
  • Table 12. Albumin: by Type(USD/Units)
  • Table 13. Research Programs/Design for This Report
  • Table 14. Key Data Information from Secondary Sources
  • Table 15. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Albumin: by Type USD/Units (2018-2023)
  • Figure 5. Albumedix (Denmark) Revenue, Net Income and Gross profit
  • Figure 6. Albumedix (Denmark) Revenue: by Geography 2023
  • Figure 7. Albumin Therapeutics, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 8. Albumin Therapeutics, LLC (United States) Revenue: by Geography 2023
  • Figure 9. Biotest AG (Germany) Revenue, Net Income and Gross profit
  • Figure 10. Biotest AG (Germany) Revenue: by Geography 2023
  • Figure 11. Octapharma AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 12. Octapharma AG (Switzerland) Revenue: by Geography 2023
  • Figure 13. CSL Behring LLC (United States) Revenue, Net Income and Gross profit
  • Figure 14. CSL Behring LLC (United States) Revenue: by Geography 2023
  • Figure 15. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Baxter International, Inc. (United States) Revenue: by Geography 2023
  • Figure 17. HiMedia Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 18. HiMedia Laboratories (India) Revenue: by Geography 2023
  • Figure 19. MedxBio Pte. Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 20. MedxBio Pte. Ltd. (Singapore) Revenue: by Geography 2023
  • Figure 21. Novozymes A/S. (Denmark) Revenue, Net Income and Gross profit
  • Figure 22. Novozymes A/S. (Denmark) Revenue: by Geography 2023
  • Figure 23. Mitsubishi Tanabe Pharma (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Mitsubishi Tanabe Pharma (Japan) Revenue: by Geography 2023
  • Figure 25. Global Albumin: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Albumedix (Denmark)
  • Albumin Therapeutics, LLC (United States)
  • Biotest AG (Germany)
  • Octapharma AG (Switzerland)
  • CSL Behring LLC (United States)
  • Baxter International, Inc. (United States)
  • HiMedia Laboratories (India)
  • MedxBio Pte. Ltd. (Singapore)
  • Novozymes A/S. (Denmark)
  • Mitsubishi Tanabe Pharma (Japan)
Additional players considered in the study are as follows:
Sigma-Aldrich Corporation (United States) , China Biologic Products Inc. (China) , Thermo Fisher Scientific (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 216 Pages 95 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Albumin Quantitative research analysis
Global Albumin Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Albumin market are Albumedix (Denmark), Albumin Therapeutics, LLC (United States), Biotest AG (Germany), Octapharma AG (Switzerland), CSL Behring LLC (United States), Baxter International, Inc. (United States), HiMedia Laboratories (India), MedxBio Pte. Ltd. (Singapore), Novozymes A/S. (Denmark) and Mitsubishi Tanabe Pharma (Japan), to name a few.
is dominating the Albumin Market.
"Pricing Pressure Faced By Prominent Player in the Market " is seen as one of the major challenges by many Industry Players of Albumin Market
The Albumin market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Albumin market is expected to see a steady growth rate during projected year 2023 to 2030.

Know More About Global Albumin Report?

Have a Query? Click Here

Other Related Reports

Acne Drugs Comprehensive Study by Mode of Administration (Oral, Topical, Injectable), Therapeutic Class (Retinoid, Antibiotic, Hormonal Agent, Combination, Others), Age Group (0-10 years, 11-16 years...
$ 3450
Hepatitis A Vaccine Comprehensive Study by Type (Liver Inactivated Vaccine, Live Attenuated Vaccine), Application (Hospitals & Clinics,, Others (Organizations Associated with Government Vaccinations ...
$ 3750
Anti-Suicide Drug Comprehensive Study by Type (Anti-Depressants and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), Application (Hospital, Clinic, Home Use), Distributi...
$ 3800
Actinic Keratosis Drugs Comprehensive Study by Type (Nucleoside metabolic inhibitors, Immunomodulators, Photosensitizing agents, NSAIDs), Way of Intake (Tablets, Cream, Other), End User (Hospitals, C...
$ 3450
Medium-chain Triglycerides Comprehensive Study by Type (Caprylic Acid, Capric Acid, Lauric Acid, Caproic Acid), Application (Nutritional Diet, Personal Care, Pharmaceuticals, Sports Drinks, Infant Fo...
$ 3450
Antacid Tablet Comprehensive Study by Type (Ca-based, Mg-based, Mixed), Application (In-Patient, Out-Patient), Distribution Chanel (Hospital Pharmacies, Retail Pharmacies, Others) Players and Region ...
$ 3500